NEW YORK, June 19, 2017 /PRNewswire/ -- CEFALY Technology announced today that Cefaly®, the first FDA-approved external trigeminal nerve stimulation device for the prevention of frequent episodic ...
The Buy Back allows CEFALY users to trade up their device for a smaller, sleeker, device with two migraine treatment programs, rechargeable battery, and a renewed 60-day money back guarantee NEW YORK, ...
Cefaly is an external trigeminal nerve stimulation (eTNS) device used as a preventive treatment measure for migraine. It’s approved by the Food and Drug Administration (FDA), and it’s thought to work ...
DARIEN, Conn., June 28, 2022 /PRNewswire/ -- CEFALY Technology has partnered with Ordergroove, the leader in Relationship Commerce, to offer an upgraded electrode subscription experience to its ...
Though using electrical stimulation of the brain as a means of treating migraines has provided an alternative to over-the-counter medication, the administering of the electrical currents can be ...
A high tech headband could offer relief for millions of people who suffer with migraines. England's health watchdog gave the green light for the new Cefaly device to be used on the NHS. The £250 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback